These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26522088)

  • 1. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
    Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
    Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate binding mode and its implication on drug design for botulinum neurotoxin A.
    Kumaran D; Rawat R; Ahmed SA; Swaminathan S
    PLoS Pathog; 2008 Sep; 4(9):e1000165. PubMed ID: 18818739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate.
    Zuniga JE; Schmidt JJ; Fenn T; Burnett JC; Araç D; Gussio R; Stafford RG; Badie SS; Bavari S; Brunger AT
    Structure; 2008 Oct; 16(10):1588-97. PubMed ID: 18940613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
    Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
    Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV; Aoki KR; Atassi MZ
    Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
    Agarwal R; Binz T; Swaminathan S
    Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
    Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
    Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE; Cai F; Neale EA
    Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding.
    Burnett JC; Schmidt JJ; McGrath CF; Nguyen TL; Hermone AR; Panchal RG; Vennerstrom JL; Kodukula K; Zaharevitz DW; Gussio R; Bavari S
    Bioorg Med Chem; 2005 Jan; 13(2):333-41. PubMed ID: 15598556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling.
    Kumar G; Kumaran D; Ahmed SA; Swaminathan S
    Acta Crystallogr D Biol Crystallogr; 2012 May; 68(Pt 5):511-20. PubMed ID: 22525749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.
    Yao G; Lam KH; Weisemann J; Peng L; Krez N; Perry K; Shoemaker CB; Dong M; Rummel A; Jin R
    Sci Rep; 2017 Aug; 7(1):7438. PubMed ID: 28785006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.
    Dhaliwal HK; Thiruvanakarasu N; Kumar R; Patel K; Ambrin G; Cai S; Singh BR
    Protein J; 2017 Dec; 36(6):489-501. PubMed ID: 29030733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
    Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.
    Masuyer G; Zhang S; Barkho S; Shen Y; Henriksson L; Košenina S; Dong M; Stenmark P
    Sci Rep; 2018 Mar; 8(1):4518. PubMed ID: 29540745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
    Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
    Teng YH; Berger WT; Nesbitt NM; Kumar K; Balius TE; Rizzo RC; Tonge PJ; Ojima I; Swaminathan S
    Bioorg Med Chem; 2015 Sep; 23(17):5489-95. PubMed ID: 26275678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.